The Treatment of Acute Leukemia: Observations by a Marrow Transplanter

  • E. D. Thomas
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 36)

Abstract

When I graduated from medical school in 1946 the diagnosis of leukemia was a sentence of death. There were two developments near the end of the 1940s which were destined to change this dismal outlook. The first was the demonstration by Farber et al. [1] that a remission could be induced in children with acute lymphoblastic leukemia (ALL) by the use of an anti-folic antimetabolite. The second was the demonstration by Jacobson et al. [2] that mice could be protected from otherwise lethal irradiation by shielding the spleen, an observation that eventually led to the recognition of the potential role of marrow transplantation in the treatment of leukemia.

Keywords

Toxicity Leukemia Pneumonia Oncol Radioactive Isotope 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Farber S, Diamond LK, Mercer RD, Sylvester RF Jr., Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4 — aminopteroyl — g1utamic acid (aminopterin). N Engl J Med 238: 787–791PubMedCrossRefGoogle Scholar
  2. 2.
    Jacobson LO, Marks EK, Robsen MJ, Gaston EO, Zirkle RE (1949) Effect of spleen protection on mortality following x-irradiation. J Lab Clin Med 34: 1538–1543Google Scholar
  3. 3.
    Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation. N Engl J Med 292: 832–843, 895–902PubMedCrossRefGoogle Scholar
  4. 4.
    Thomas ED, Flournoy N, Buckner CD, Clift RA, Fefer A, Neiman PE, Storb R (1977) Cure of leukemia by marrow transplantation. Leuk Res 1: 67–70CrossRefGoogle Scholar
  5. 5.
    Powles RL, Morgenstern G, Clink HM, Hedley D, Bandini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Jameson B, Lawler S, Kay HEM, McElwain TJ (1980) The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet i: 1047–1050CrossRefGoogle Scholar
  6. 6.
    Champlin RE, Ho WG, Gale RP, Winston D, Selch M, Mitsuyasu R, Lenarsky C, Elashoff R, Zighelboim J, Feig SA (1985) Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 102: 285–291PubMedGoogle Scholar
  7. 7.
    Ringdén O, Bolme P, Lönnqvist B, Gustafsson G, Kreuger A (1992) Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden. Ped Hematol Oncol 6: 137–144CrossRefGoogle Scholar
  8. 8.
    Appelbaum FR, Fisher LD, Thomas ED, and the Seattle Marrow Transplant Team (1988) Chemotherapy v marrow transplantation for adults with acute non lymphocytic leukemia: A five-year follow-up. Blood 72: 179–184PubMedGoogle Scholar
  9. 9.
    Dahl GV, Kalwinsky DK, Mirro J, Jr., Look AT, Pui C-H, Murphy SB, Mason C, Ruggiero M, Schell M, Johnson FL, Thomas ED (1990) Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8: 295–303PubMedGoogle Scholar
  10. 10.
    Nesbit ME, Jr., Buckley J, Feig SA, Anderson J, Lampkin B, Bernstein ID, Kim TH, Piomelli S, Kersey JH, Coccia PF, O’Reilly RJ, August C, Thomas ED, Hammond GO: Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multi-agent chemotherapy. A report from the Children’s Study Group. (Manuscript in preparation) Google Scholar
  11. 11.
    Appelbaum FR, Hewlett J, Kopecky K, Angle C, Coltman C (1986) Prospective comparative study of bone marrow transplantation (BMT) versus continued chemotherapy for adult acute nonlymphocytic leukemia (ANL): A southwest oncology group study. Blood 68 (Supp. 1): 216a, (Abstract)Google Scholar
  12. 12.
    Creutzig U, Ritter J, Schellong G (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 75: 1932–1940PubMedGoogle Scholar
  13. 13.
    Tallman MS, Kopecky KJ, Amos D, Dahlberg S, Hewlett JS, Files JC, Coltman CA, Thomas ED, Appelbaum FR (1989) Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. J Clin Oncol 7: 326–337PubMedGoogle Scholar
  14. 14.
    Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G, Hiddemann W, Kolb H-J, Löffer H, Marmont AM, Maschmeyer G, Rimm AA, Rozman C, Sobocinski KA, Speck B, Thiel E, Weisdorf DJ, Zwaan FE, Bortin MM (1991) Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 115: 13–18PubMedGoogle Scholar
  15. 15.
    Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511–533PubMedGoogle Scholar
  16. 16.
    Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED (1983) Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61: 949–953PubMedGoogle Scholar
  17. 17.
    Thomas ED, Sanders JE, Flournoy N, Johnson FL, Buckner CD, Clift RA, Fefer A, Goodell BW, Storb R, Weiden PL (1979) Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54: 468–476PubMedGoogle Scholar
  18. 18.
    Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R (1981) A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 305: 846–851.PubMedCrossRefGoogle Scholar
  19. 19.
    Sanders JE, Thomas ED, Buckner CD, Doney K (1987) Marrow transplantation for children with acute lymphoblastic leukemia in second remission. (Concise Report). Blood 70: 324–326PubMedGoogle Scholar
  20. 20.
    Dopfer R, Henze G, Bender-Götze C, Bell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H, Suttorp M, Schmid H, Schmitz N, Siegert W, Stollman-Gibbels B, Hartmann R, Niethammer D (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-Protocols: Results of the German Cooperative Study. Blood 78: 2780–2784PubMedGoogle Scholar
  21. 21.
    Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD (1982) Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind trial. Ann Intern Med 96: 265–269PubMedGoogle Scholar
  22. 22.
    Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324: 1005–1011PubMedCrossRefGoogle Scholar
  23. 23.
    Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M, Buckner CD, Hansen JA, Ritz J, Appelbaum FR, Armitage JO, Nadler LM (1991) Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324: 1773–1778PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • E. D. Thomas
    • 1
  1. 1.Fred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations